Tower Research Capital LLC (Trc) Merrimack Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.06 - $15.0 $12,877 - $14,790	-986 Reduced 77.88%	280 $4,000
Q4 2023 Feb 13, 2024	BUY	$12.02 - $13.41 $1,226 - $1,367	102 Added 8.76%	1,266 $16,000
Q3 2023 Nov 14, 2023	SELL	$11.6 - $12.52 $109,074 - $117,725	-9,403 Reduced 88.98%	1,164 $14,000
Q2 2023 Aug 14, 2023	BUY	$12.02 - $13.07 $112,170 - $121,969	9,332 Added 755.63%	10,567 $129,000
Q1 2023 May 09, 2023	SELL	$11.35 - $12.32 $22,779 - $24,726	-2,007 Reduced 61.91%	1,235 $15,000
Q4 2022 Feb 10, 2023	BUY	$3.68 - $12.51 $11,249 - $38,243	3,057 Added 1652.43%	3,242 $37,000
Q3 2022 Nov 10, 2022	BUY	$3.7 - $6.06 $462 - $757	125 Added 208.33%	185 $1,000
Q2 2022 Aug 15, 2022	SELL	$4.89 - $7.13 $650 - $948	-133 Reduced 68.91%	60 $0
Q1 2022 May 12, 2022	SELL	$3.75 - $6.82 $1,631 - $2,966	-435 Reduced 69.27%	193 $1,000
Q4 2021 Feb 14, 2022	BUY	$3.75 - $5.1 $2,103 - $2,861	561 Added 837.31%	628 $2,000
Q3 2021 Nov 15, 2021	BUY	$4.3 - $6.39 $288 - $428	67 New	67 $0
Q2 2021 Aug 16, 2021	SELL	$6.04 - $7.77 $15,577 - $20,038	-2,579 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.15 - $8.7 $3,880 - $5,489	631 Added 32.39%	2,579 $16,000
Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $5,346 - $12,041	1,449 Added 290.38%	1,948 $13,000
Q3 2020 Nov 16, 2020	BUY	$3.1 - $4.3 $1,546 - $2,145	499 New	499 $2,000
Q2 2020 Aug 13, 2020	SELL	$2.21 - $3.88 $1,708 - $2,999	-773 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.63 - $3.58 $2,868 - $6,300	-1,760 Reduced 69.48%	773 $2,000
Q4 2019 Feb 07, 2020	SELL	$3.15 - $4.67 $973 - $1,443	-309 Reduced 10.87%	2,533 $8,000
Q3 2019 Nov 05, 2019	SELL	$4.16 - $6.05 $1,892 - $2,752	-455 Reduced 13.8%	2,842 $13,000
Q2 2019 Aug 13, 2019	BUY	$4.39 - $5.66 $10,773 - $13,889	2,454 Added 291.1%	3,297 $20,000
Q1 2019 May 14, 2019	SELL	$3.19 - $5.73 $58,121 - $104,400	-18,220 Reduced 95.58%	843 $6,000
Q4 2018 Feb 14, 2019	BUY	$2.95 - $4.15 $8,953 - $12,595	3,035 Added 18.94%	19,063 $73,000
Q3 2018 Nov 13, 2018	BUY	$3.91 - $4.66 $34,458 - $41,068	8,813 Added 122.15%	16,028 $86,000
Q2 2018 Aug 15, 2018	BUY	$3.86 - $7.61 $21,006 - $41,413	5,442 Added 306.94%	7,215 $36,000
Q1 2018 May 15, 2018	BUY	$6.24 - $9.15 $11,063 - $16,222	1,773 New	1,773 $14,000
Q4 2017 Feb 09, 2018	SELL	$7.99 - $11.87 $27,589 - $40,987	-3,453 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $31,525 - $40,469	3,453	3,453 $50,000

Others Institutions Holding MACK

# of Institutions

Shares Held

349

Call Options Held

Put Options Held

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account